Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
133 participants
OBSERVATIONAL
2014-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)
NCT00512109
Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2
NCT07300579
Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device
NCT05996965
Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge - A Pilot Study
NCT02786940
Home Monitoring for Thoracic Surgery Patients
NCT04340960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will have postoperative Troponin I monitoring and telephone follow-up at 30 days postop.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ECG, blood pressure and oximetry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of stroke or transient ischemic attack (TIA)
* History of hypertension
* History of diabetes
* History of peripheral vascular disease
* History of congestive heart failure
* Preoperative creatinine \> 175 umol/L
* A planned admission for ≥48 hours
* Patients receiving a general or regional anesthetic
Exclusion Criteria
* Patients who undergo procedure performed under infiltrative or topical anesthesia.
* Patients previously enrolled in the HI-VISION Study.
* Patients who refuse 30-day follow-up.
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamilton Health Sciences Corporation
OTHER
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip J. Devereaux, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Juravinski Hospital
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HI-VISION Pilot Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.